Cargando…
440. Steroid Use and Elevated Rates of Coinfections and Mortality in Mild-COVID-19 Patients
BACKGROUND: Systemic corticosteroids are used to treat patients with COVID-19. Since the findings of the RECOVERY trial, steroids have been broadly used in critical patients. However, their use in patients with mild disease was unclear and may even be harmful. In the hard times of the pandemic in th...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676924/ http://dx.doi.org/10.1093/ofid/ofad500.510 |
_version_ | 1785150008633327616 |
---|---|
author | Rebellon-Sanchez, David E Llanos-Torres, Julio Álvarez-Ortega, Carolina Guzman-Gonzales, Tania M Rodríguez, Sarita Rosso, Fernando |
author_facet | Rebellon-Sanchez, David E Llanos-Torres, Julio Álvarez-Ortega, Carolina Guzman-Gonzales, Tania M Rodríguez, Sarita Rosso, Fernando |
author_sort | Rebellon-Sanchez, David E |
collection | PubMed |
description | BACKGROUND: Systemic corticosteroids are used to treat patients with COVID-19. Since the findings of the RECOVERY trial, steroids have been broadly used in critical patients. However, their use in patients with mild disease was unclear and may even be harmful. In the hard times of the pandemic in the absence of widely available vaccines or antivirals agents, hospital overcrowding, patients had to be referred to home care and steroids could be overused. The aim of this study was to explore the relationship between the use of corticosteroids, secondary infections and overall mortality in adults with COVID-19 METHODS: A prospective observational study was performed in a university hospital in Cali, Colombia. Severity was assessed with NEWS score 2. The study included patients at various levels of severity, including patients admitted to the emergency department, inpatients, and those admitted to the intensive care unit RESULTS: A total of 12,227 patients were treated at our hospital during the first four waves of the pandemic. 54.8% were female, with median age of 45 years (IQR: 31 - 62). 68.5% were classified as mild COVID-19, 8.8% as moderate, and 22.68% as severe. 5.49% of patients were pregnant. Of all patients, 24.30% received corticosteroids upon admission, 11.6% developed secondary infections, and 8.4% died. Mild COVID-19 cases were 1,988 (wave 1), 2,147 (wave 2), 1,628 (wave 3), and 1,608 (wave 4). The proportions of corticosteroid used by waves were 4.3%, 7.18%, 12.5%, and 8.1%, respectively. Corresponding proportions for secondary infections were 2.80%, 5.26%, 6.14%, and 3.8%, while death proportions were 1.7%, 2.5%, 3.2%, and 2.1%. A positive correlation was found between corticosteroid use and secondary infection and mortality rates (Fig. 1). Correlation coefficients were r= 0.9 (p= 0.09) for corticosteroid use and mortality, r= 0.84 (p= 0.15) for corticosteroid use and secondary infection, and r= 0.94 (p= 0.01) for secondary infection and mortality. These correlations were not observed in moderate and severe COVID-19 cases Relationship between corticosteroid use, secondary infection and mortality in patients with COVID-19 [Figure: see text] A. Relationship in mild COVID-19 patients. B. Relationship in moderate-to-severe COVID-19 patients CONCLUSION: Our study shows that the use of corticosteroids in mild cases could correlate with a greater proportion of secondary infections and mortality DISCLOSURES: All Authors: No reported disclosures |
format | Online Article Text |
id | pubmed-10676924 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-106769242023-11-27 440. Steroid Use and Elevated Rates of Coinfections and Mortality in Mild-COVID-19 Patients Rebellon-Sanchez, David E Llanos-Torres, Julio Álvarez-Ortega, Carolina Guzman-Gonzales, Tania M Rodríguez, Sarita Rosso, Fernando Open Forum Infect Dis Abstract BACKGROUND: Systemic corticosteroids are used to treat patients with COVID-19. Since the findings of the RECOVERY trial, steroids have been broadly used in critical patients. However, their use in patients with mild disease was unclear and may even be harmful. In the hard times of the pandemic in the absence of widely available vaccines or antivirals agents, hospital overcrowding, patients had to be referred to home care and steroids could be overused. The aim of this study was to explore the relationship between the use of corticosteroids, secondary infections and overall mortality in adults with COVID-19 METHODS: A prospective observational study was performed in a university hospital in Cali, Colombia. Severity was assessed with NEWS score 2. The study included patients at various levels of severity, including patients admitted to the emergency department, inpatients, and those admitted to the intensive care unit RESULTS: A total of 12,227 patients were treated at our hospital during the first four waves of the pandemic. 54.8% were female, with median age of 45 years (IQR: 31 - 62). 68.5% were classified as mild COVID-19, 8.8% as moderate, and 22.68% as severe. 5.49% of patients were pregnant. Of all patients, 24.30% received corticosteroids upon admission, 11.6% developed secondary infections, and 8.4% died. Mild COVID-19 cases were 1,988 (wave 1), 2,147 (wave 2), 1,628 (wave 3), and 1,608 (wave 4). The proportions of corticosteroid used by waves were 4.3%, 7.18%, 12.5%, and 8.1%, respectively. Corresponding proportions for secondary infections were 2.80%, 5.26%, 6.14%, and 3.8%, while death proportions were 1.7%, 2.5%, 3.2%, and 2.1%. A positive correlation was found between corticosteroid use and secondary infection and mortality rates (Fig. 1). Correlation coefficients were r= 0.9 (p= 0.09) for corticosteroid use and mortality, r= 0.84 (p= 0.15) for corticosteroid use and secondary infection, and r= 0.94 (p= 0.01) for secondary infection and mortality. These correlations were not observed in moderate and severe COVID-19 cases Relationship between corticosteroid use, secondary infection and mortality in patients with COVID-19 [Figure: see text] A. Relationship in mild COVID-19 patients. B. Relationship in moderate-to-severe COVID-19 patients CONCLUSION: Our study shows that the use of corticosteroids in mild cases could correlate with a greater proportion of secondary infections and mortality DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10676924/ http://dx.doi.org/10.1093/ofid/ofad500.510 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract Rebellon-Sanchez, David E Llanos-Torres, Julio Álvarez-Ortega, Carolina Guzman-Gonzales, Tania M Rodríguez, Sarita Rosso, Fernando 440. Steroid Use and Elevated Rates of Coinfections and Mortality in Mild-COVID-19 Patients |
title | 440. Steroid Use and Elevated Rates of Coinfections and Mortality in Mild-COVID-19 Patients |
title_full | 440. Steroid Use and Elevated Rates of Coinfections and Mortality in Mild-COVID-19 Patients |
title_fullStr | 440. Steroid Use and Elevated Rates of Coinfections and Mortality in Mild-COVID-19 Patients |
title_full_unstemmed | 440. Steroid Use and Elevated Rates of Coinfections and Mortality in Mild-COVID-19 Patients |
title_short | 440. Steroid Use and Elevated Rates of Coinfections and Mortality in Mild-COVID-19 Patients |
title_sort | 440. steroid use and elevated rates of coinfections and mortality in mild-covid-19 patients |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676924/ http://dx.doi.org/10.1093/ofid/ofad500.510 |
work_keys_str_mv | AT rebellonsanchezdavide 440steroiduseandelevatedratesofcoinfectionsandmortalityinmildcovid19patients AT llanostorresjulio 440steroiduseandelevatedratesofcoinfectionsandmortalityinmildcovid19patients AT alvarezortegacarolina 440steroiduseandelevatedratesofcoinfectionsandmortalityinmildcovid19patients AT guzmangonzalestaniam 440steroiduseandelevatedratesofcoinfectionsandmortalityinmildcovid19patients AT rodriguezsarita 440steroiduseandelevatedratesofcoinfectionsandmortalityinmildcovid19patients AT rossofernando 440steroiduseandelevatedratesofcoinfectionsandmortalityinmildcovid19patients |